Rheumatology and immunology research · 2026
Health service capacity of rheumatology and immunology departments in China: A cross-sectional study of young and middle-aged physicians.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Qiao Lin, Geng Yan, Zhao Ling, Wu Chanyuan, Mo Yingqian, Chen Zhu, Xu Xiangfeng, Duan Lihua, Zhao Yi, Zhao Jiuliang, Wang Qian, Zhao Yan
Аннотация
BACKGROUND AND OBJECTIVES: Rheumatic diseases are among the most prevalent chronic health conditions worldwide. This study aimed to systematically assess the diagnostic, therapeutic, and service capabilities of rheumatology and immunology departments across China.
METHODS: A questionnaire-based survey was conducted among young and middle-aged rheumatologists from May to November 2023. The questionnaire collected data on demographics, departmental infrastructure, and service capabilities.
RESULTS: A total of 2047 rheumatologists from 934 hospitals completed the survey. Among the participating hospitals, 817 (87.5%) were tertiary institutions. Most respondents (1970/2047, 96.5%) reported that their hospitals had rheumatology and immunology departments. With respect to the departmental scale, 65.0% of the respondents reported having 20-50 inpatient beds, and 39.0% (603/1546) of the departments had 6-10 physicians. Only 33.8% (691/2045) of the hospitals were capable of performing basic immunologic blood tests. The availability of key modalities was as follows: dual-energy CT (60.6%, 1238/2044), musculoskeletal ultrasound (87.0%, 1778/2044), sacroiliac joint CT (90.9%, 1857/2044), labial gland biopsy (81.3%, 1662/2044), renal biopsy (80.6%, 1647/2044), and synovial biopsy (62.6%, 1280/2044). Most surveyed physicians used Western medicine for patient treatment. In addition, 89.0% (1806/2030) of the respondents reported conducting follow-up for patients with chronic rheumatic disease.
CONCLUSIONS: Rheumatology is among the fastest-growing specialties. Our survey highlights the need to enhance public awareness, optimize specialist training, and strengthen healthcare delivery and academic research. With increasing national attention, we anticipate considerable advancements in the fields of rheumatology and immunology in China.
METHODS: A questionnaire-based survey was conducted among young and middle-aged rheumatologists from May to November 2023. The questionnaire collected data on demographics, departmental infrastructure, and service capabilities.
RESULTS: A total of 2047 rheumatologists from 934 hospitals completed the survey. Among the participating hospitals, 817 (87.5%) were tertiary institutions. Most respondents (1970/2047, 96.5%) reported that their hospitals had rheumatology and immunology departments. With respect to the departmental scale, 65.0% of the respondents reported having 20-50 inpatient beds, and 39.0% (603/1546) of the departments had 6-10 physicians. Only 33.8% (691/2045) of the hospitals were capable of performing basic immunologic blood tests. The availability of key modalities was as follows: dual-energy CT (60.6%, 1238/2044), musculoskeletal ultrasound (87.0%, 1778/2044), sacroiliac joint CT (90.9%, 1857/2044), labial gland biopsy (81.3%, 1662/2044), renal biopsy (80.6%, 1647/2044), and synovial biopsy (62.6%, 1280/2044). Most surveyed physicians used Western medicine for patient treatment. In addition, 89.0% (1806/2030) of the respondents reported conducting follow-up for patients with chronic rheumatic disease.
CONCLUSIONS: Rheumatology is among the fastest-growing specialties. Our survey highlights the need to enhance public awareness, optimize specialist training, and strengthen healthcare delivery and academic research. With increasing national attention, we anticipate considerable advancements in the fields of rheumatology and immunology in China.